A titer of 1 1:40 was considered positive and a four-fold rise in HI above levels before vaccination or seronegative to seropositive was considered as seroconversion

A titer of 1 1:40 was considered positive and a four-fold rise in HI above levels before vaccination or seronegative to seropositive was considered as seroconversion. == Influenza specific cell proliferation == Fresh peripheral blood mononuclear cells (PBMCs) were separated from whole blood by Ficoll-Hypaque (GE Healthcare Life Sciences) gradient and stimulated with influenza A H1N1, A H3N2 and B antigen prepared from infected Madin-Darby Canine Kidney (MDCK) cell lysates in triplicate wells, the medium was used as negative control. hemagglutination inhibition test and influenza-specific memory B, TCD4+, and TCD8 + lymphocytes were determined by flow cytometry. All the asthmatic patients received ICS treatment. The Geometric Mean titers for all influenza serotypes were similar in both groups; seropositivity and the cellular immune response increased in both groups over time and was comparable. Influenza vaccination in asthmatic patients with immunotherapy and ICS achieved protective antibody levels and cellular immunity over time comparable to healthy subjects. KEYWORDS:Asthma, adults, influenza vaccine, cellular and humoral immune response == Introduction == The influenza virus causes respiratory disease in humans affecting the upper and lower respiratory airways, and has the ability to cause epidemics and pandemics.1Influenza in asthmatic patients is associated with an increase in health care services (hospital admissions, clinic visits, ancillary services, and emergency department visits).2Patients with asthma may have exacerbations, worst symptoms, risk of pneumonia, viral lower respiratory tract infection, bronchiolitis, secondary bacterial infection, sepsis and a prolonged decline in lung function after an influenza episode.3In addition, influenza remains one of the most common causes of hospitalization for asthma exacerbation in children.4 Influenza vaccination is recommended by the World Health Organization (WHO) for all people older than 6 months who do not have contraindications and especially high-risk priority groups, Mouse monoclonal to CD2.This recognizes a 50KDa lymphocyte surface antigen which is expressed on all peripheral blood T lymphocytes,the majority of lymphocytes and malignant cells of T cell origin, including T ALL cells. Normal B lymphocytes, monocytes or granulocytes do not express surface CD2 antigen, neither do common ALL cells. CD2 antigen has been characterised as the receptor for sheep erythrocytes. This CD2 monoclonal inhibits E rosette formation. CD2 antigen also functions as the receptor for the CD58 antigen(LFA-3) including people with chronic illnesses such as asthma, and health care workers.5,6However, the effectiveness of influenza vaccine depends primarily on the age and immunocompetence of the subjects, and the degree of similarity between the viruses in the vaccine and those in circulation.7The influenza vaccination is safe in the asthmatic population as has been demonstrated in multiple studies in children and adults, without worsening asthma symptoms, exacerbations or decrease in peak expiratory Narirutin flow rates.8,9Asthmatic patients should be vaccinated annually according to GINA recommendation since it prevents exacerbations, although there is concern about the immune response, especially in those receiving a high dose of inhaled steroids.10However, previous studies in patients with moderate to severe asthma showed that oral prednisone exposures did not decrease the immune response to influenza vaccination in children.11Although, this study only measured influenza-specific antibodies. The immune response generated by pathogens including vaccines includes innate and adaptive immunity with a humoral and a cellular component. The humoral immunity is composed mainly of B cells that produce high-affinity and specific antibodies and the cellular immunity is divided into antigen-specific CD4 T-cells, who produce several cytokines and other stimulatory factors and the CD8T-cells with the ability to kill infected cells. Immune memory is generated within the adaptive immune response with development of antigen-high specificity and the capacity to rapidly generate large numbers of antigen-specific CD4, CD8 T cells and antibodies. The goal of a vaccine is to induce long-term immunological memory. However, Narirutin many of the vaccines currently in use were developed with a little understanding of the cellular immune response.12 The memory T cells differ from nave and effector T cells in several ways.13,14At least two types of memory T cells have been described within the CD4 and CD8 T cell populations based on their homing characteristics and their effector functions. In humans, T effector-memory (TEM) and T central-memory (TCM) cells differ both functionally and in their migratory properties and can be distinguished based on their CD62L and CCR7 surface expression. TCM cells express CCR7 and CD62L, whereas TEM cells do Narirutin not express CCR7 or CD62L.15 Asthmatic patients have been described with a Th2 and/or Th17 pattern that could predispose to a different immune response to vaccines. The aim of this study was to characterize the cellular and humoral immune responses to influenza vaccination in asthmatic and healthy subjects. == Materials and methods == == Study population and study procedures == A prospective, longitudinal, comparative, clinical trial was performed. Asthmatic patients who attend the Allergy and Clinical Immunology Service at the Hospital General de Mxico, Dr. Eduardo Liceaga and healthy subjects were invited to participate in the study and signed a written informed consent. Inclusion criteria were mild to moderate asthma according to GINA (Global Initiative for Asthma) guidelines and age-matched healthy subjects. Exclusion criteria were egg allergy, previous allergic reaction to influenza vaccine, immunodeficiencies, and acute respiratory.